News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,436 Results
Type
Article (42676)
Company Profile (283)
Press Release (686466)
Multimedia
Podcasts (91)
Webinars (17)
Section
Business (206198)
Career Advice (2039)
Deals (35717)
Drug Delivery (120)
Drug Development (81965)
Employer Resources (173)
FDA (16608)
Job Trends (15038)
News (349079)
Policy (33223)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2619)
Accelerated approval (36)
Adcomms (25)
Allergies (152)
Alliances (50291)
ALS (175)
Alzheimer's disease (1700)
Antibody-drug conjugate (ADC) (331)
Approvals (16861)
Artificial intelligence (550)
Autoimmune disease (166)
Automation (45)
Bankruptcy (363)
Best Places to Work (11685)
BIOSECURE Act (22)
Biosimilars (204)
Biotechnology (186)
Bladder cancer (164)
Brain cancer (59)
Breast cancer (657)
Cancer (4983)
Cardiovascular disease (412)
Career advice (1724)
Career pathing (37)
CAR-T (287)
CDC (50)
Celiac Disease (2)
Cell therapy (772)
Cervical cancer (37)
Clinical research (70094)
Collaboration (1776)
Company closure (4)
Compensation (1182)
Complete response letters (64)
COVID-19 (2765)
CRISPR (96)
C-suite (890)
Cystic fibrosis (145)
Data (6422)
Decentralized trials (2)
Denatured (30)
Depression (137)
Diabetes (515)
Diagnostics (6776)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (270)
Drug pricing (192)
Drug shortages (28)
Duchenne muscular dystrophy (242)
Earnings (90624)
Editorial (62)
Employer branding (21)
Employer resources (152)
Events (118467)
Executive appointments (1003)
FDA (19824)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (24)
Funding (1520)
Gene editing (206)
Generative AI (46)
Gene therapy (627)
GLP-1 (990)
Government (4790)
Grass and pollen (6)
Guidances (385)
Healthcare (18971)
HIV (68)
Huntington's disease (51)
IgA nephropathy (84)
Immunology and inflammation (266)
Immuno-oncology (67)
Indications (126)
Infectious disease (3053)
Inflammatory bowel disease (201)
Inflation Reduction Act (14)
Influenza (124)
Intellectual property (259)
Interviews (317)
IPO (16711)
IRA (51)
Job creations (3684)
Job search strategy (1439)
JPM (58)
Kidney cancer (18)
Labor market (87)
Layoffs (557)
Leadership (34)
Legal (8013)
Liver cancer (93)
Longevity (17)
Lung cancer (673)
Lymphoma (383)
Machine learning (43)
Management (59)
Manufacturing (845)
MASH (166)
Medical device (13862)
Medtech (13922)
Mergers & acquisitions (20092)
Metabolic disorders (1302)
mRNA (165)
Multiple sclerosis (167)
NASH (16)
Neurodegenerative disease (336)
Neuropsychiatric disorders (90)
Neuroscience (2987)
Neurotech (1)
NextGen: Class of 2026 (6570)
Non-profit (4545)
Now hiring (69)
Obesity (611)
Opinion (274)
Ovarian cancer (169)
Pain (205)
Pancreatic cancer (239)
Parkinson's disease (294)
Partnered (34)
Patents (519)
Patient recruitment (519)
Peanut (62)
People (59382)
Pharmaceutical (64)
Pharmacy benefit managers (30)
Phase 1 (21877)
Phase 2 (30819)
Phase 3 (22997)
Pipeline (5755)
Policy (309)
Postmarket research (2580)
Preclinical (9289)
Press Release (71)
Prostate cancer (250)
Psychedelics (50)
Radiopharmaceuticals (289)
Rare diseases (900)
Real estate (6046)
Recruiting (70)
Regulatory (25008)
Reports (53)
Research institute (2433)
Resumes & cover letters (354)
Rett syndrome (29)
RNA editing (17)
RSV (82)
Schizophrenia (153)
Series A (251)
Series B (195)
Service/supplier (11)
Sickle cell disease (103)
Special edition (22)
Spinal muscular atrophy (159)
Sponsored (43)
Startups (3673)
State (2)
Stomach cancer (18)
Supply chain (107)
Tariffs (86)
The Weekly (59)
Vaccines (1052)
Venture capital (89)
Weight loss (391)
Women's health (97)
Worklife (19)
Date
Today (238)
Last 7 days (876)
Last 30 days (2845)
Last 365 days (30282)
2026 (4793)
2025 (30465)
2024 (35477)
2023 (40333)
2022 (51488)
2021 (56038)
2020 (54404)
2019 (46849)
2018 (35303)
2017 (32484)
2016 (31855)
2015 (37923)
2014 (31692)
2013 (26709)
2012 (28881)
2011 (29574)
2010 (27569)
Location
Africa (750)
Alabama (86)
Alaska (7)
Arizona (315)
Arkansas (14)
Asia (39982)
Australia (6506)
California (11650)
Canada (3351)
China (1132)
Colorado (488)
Connecticut (491)
Delaware (343)
Europe (86382)
Florida (1746)
Georgia (370)
Hawaii (3)
Idaho (61)
Illinois (887)
India (73)
Indiana (537)
Iowa (23)
Japan (444)
Kansas (128)
Kentucky (42)
Louisiana (27)
Maine (72)
Maryland (1436)
Massachusetts (8358)
Michigan (335)
Minnesota (647)
Mississippi (7)
Missouri (130)
Montana (32)
Nebraska (29)
Nevada (127)
New Hampshire (80)
New Jersey (3088)
New Mexico (28)
New York (3056)
North Carolina (1489)
North Dakota (10)
Northern California (5709)
Ohio (349)
Oklahoma (22)
Oregon (42)
Pennsylvania (2345)
Puerto Rico (24)
Rhode Island (49)
South America (1124)
South Carolina (68)
South Dakota (1)
Southern California (4550)
Tennessee (180)
Texas (1785)
United States (41254)
Utah (354)
Vermont (1)
Virginia (272)
Washington D.C. (82)
Washington State (937)
West Virginia (4)
Wisconsin (112)
Wyoming (2)
729,436 Results for "abcellera biologics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AbCellera Reports Full Year 2025 Business Results
February 25, 2026
·
12 min read
Press Releases
AbCellera to Present at Upcoming Investor Conferences in March and April 2026
February 12, 2026
·
1 min read
Press Releases
AbCellera to Report Full Year 2025 Financial Results on February 24, 2026
January 23, 2026
·
1 min read
Press Releases
AbCellera Appoints Dr. Stephen Quake to its Board of Directors
November 10, 2025
·
2 min read
Press Releases
AbCellera Reports Q3 2025 Business Results
November 6, 2025
·
11 min read
Press Releases
AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
December 9, 2025
·
1 min read
Press Releases
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause
January 13, 2026
·
4 min read
Press Releases
AbCellera to Participate at Upcoming Investor Conferences in November and December 2025
October 7, 2025
·
1 min read
Press Releases
AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025
September 29, 2025
·
1 min read
Press Releases
AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer
September 11, 2025
·
2 min read
1 of 72,944
Next
